genetic-and-disease Videos
4 videos found
Despite being faced with potential demise during the company’s infancy, BioMarin persevered to become one of the world leaders in developing therapies for rare genetic diseases. Watch the 20 year journey of the people of BioMarin finding tomorrows by staying focused on the science to make a big difference for small patient ...
Mar. 10, 2021
ByBioMarin
BioMarin is a global biotechnology company focused on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with serious and life-threatening rare genetic ...
Mar. 10, 2021
ByBioMarin
Introduction & Industry Update Janet Lambert, CEO, Alliance for Regenerative Medicine Emile Nuwaysir, Ph.D., CEO, Ensoma; Chairman, Alliance for Regenerative Medicine (ARM); Chairman, BlueRock Therapeutics 2022: A Banner Year for Rare Genetic Disease Therapies? Bob Smith, Senior Vice President, Global Gene Therapy Business, Pfizer Inc. ...
May. 30, 2022
However, researchers are limited in the mapping of genetic diversity of wide populations. High quality genomes are essential to resolve challenges in breeding, comparative biology, medicine and conservation planning for bottlenose dolphins. ...
Aug. 13, 2021
ByNRGene